About PPA   |   Contact Us   |   Report Abuse   |   Sign In   |   Join Now
Online Store: CE Activities
Main Storefront
        

Putting the Fire Out: Intranasal Naloxone and The Emerging Role of the Pharmacis

Item Options
Sign in for your pricing!
Price: $45.00
Quantity: *
Select Your Profession:
*
 
In order to receive CE credit for this activity, you MUST provide your CPE Monitor ID and birthday here. To look up (or sign up for) your CPE Monitor ID, visit www.mycpemonitor.net.
 
Please enter your response below: *
(of 255 characters remaining)
Description
Non-Member Access fee for Recorded CE Webinar:

Putting the Fire Out: Intranasal Naloxone and The Emerging Role of the Pharmacist

Non-members are invited to view recorded webinars and receive CE credit for a small fee.

 

Once your payment has been processed, you will receive an automated email with a link to download an electronic item. Click the link in the email - this will download a PDF file that contains a link to access the recorded webinar.

 

Please contact PPA's CPE Administrator, Sara Powers, at (717) 234-6151 x. 2 or spowers@papharmacists.com with questions.

  


Activity Details

Please read the following information about this continuing pharmacy education (CPE) activity before viewing the presentation at the bottom of this page.


UAN: 0159-0000-16-016-H01-P

Release Date: July 6, 2016
Expiration Date: July 6, 2019

Activity Type: Application-based

CE Credit: 1.5 Contact Hours (0.15 CEU)

Cost: Free for PPA members! $45 for non-members.

 

The Pennsylvania Pharmacists Association is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
 
Target Audience

All pharmacists

 

Program Description

Death from opioid overdoses is a growing epidemic in the United States, with deaths having more than tripled since 1999. Naloxone, a pure opioid antagonist, has been hypothesized as a possible agent to combat this epidemic. When administered intranasally, naloxone has been shown to be as effective as the intravenous route. This formulation, as well as the recent passing of PA Act 139, has also allowed for simple mass distribution across Pennsylvania. Despite these allowances, myths and controversies surrounding this agent, as well as the role of the pharmacist, exist. This continuing education session will describe the current opioid epidemic and the role of intranasal naloxone. It will also review the current literature base surrounding the use of intranasal naloxone and trends in opioid abuse, and finally describe the role of the pharmacist in dispensing intranasal naloxone.

 

Program Objectives

1. Describe the current opioid epidemic and the role of intranasal naloxone
2. Review the pharmacology of intranasal naloxone
3. Debate whether the utilization of intranasal naloxone will increase opioid misuse and abuse
4. Illustrate the role of the pharmacist in the dispensing of intranasal naloxone

      

Speaker

Karen Steinmetz Pater, PharmD, BCPS, CDE, Assistant Professor, University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics
Dr. Pater is an Assistant Professor at the University of Pittsburgh School of Pharmacy and an Outpatient Advanced Practice Pharmacist at the UPMC Matilda Theiss Health Center. She received her PharmD from the University of Tennessee Memphis College of Pharmacy, and completed a primary care residency at Shands Jacksonville. She is a Board Certified Pharmacotherapy Specialist and a Certified Diabetes Educator. She has spent the majority of her academic career educating students on outpatient pharmacy practice and self-care strategies. She has served as President of the Allegheny County Pharmacist Association and is the immediate Past Chair of the AACP Self-Care and Non-prescription Therapies Self-Care Sig.


Jennifer Pruskowski, PharmD, BCPS, CGP, CPE, Assistant Professor, University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics

Dr. Pruskowski is an Assistant Professor at the University of Pittsburgh School of Pharmacy and the Palliative Care Clinical Pharmacists for the UPMC Palliative and Supportive Institute. She received her PharmD from Wilkes University, completed her PGY1 Pharmacy Practice and PGY2 Geriatric Pharmacy Residency at the William Jennings Bryan Dorn Veterans Affairs Medical Center in Columbia, South Carolina, and completed her Interprofessional Palliative Care Fellowship at James J. Peters Veterans Affairs Medical Center in Bronx, New York. She is a Board Certified Pharmacotherapy Specialist, Certified Geriatric Pharmacist, and Certified Pain Educator, and has received specialized training in pain and palliative care pharmacy through the American Society of Consultant Pharmacists and the American Society of Health-System Pharmacists.



CE Requirements

To receive CE credit for this home study, you will need to watch the entire video, complete an online survey evaluation, and pass a short quiz. Access to the survey and quiz will be automatically provided after you have watched the video. PPA must have your CPE Monitor ID and birthday on file to issue credit.

 

Association Management Software Powered by YourMembership  ::  Legal